MSC Secretome and Cannabinoid Compositions for Inflammation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current therapeutics for inflammatory diseases often come with significant side effects, and there is a need for more effective treatments that can safely manage inflammation.
Innovation Solution
Compositions comprising mesenchymal stem cell (MSC) secretome preparations and cannabinoids, such as cannabidiol (CBD), are used to treat inflammatory conditions. The MSC secretome includes growth factors, extracellular vesicles, and exosomes, while cannabinoids like CBD have immunomodulatory effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional anti-inflammatory drugs (steroidal or non-steroidal) are used to treat inflammatory diseases, then inflammation is reduced, but significant side effects occur (e.g., increased blood glucose, liver toxicity, kidney failure, ulcers, bleeding)
Solution Approach 1:
The patent uses MSC secretome as an intermediary substance that mediates anti-inflammatory effects through multiple mechanisms including immunomodulation, promotion of tissue repair, and reduction of oxidative stress. This intermediary approach provides inflammation control while avoiding the direct toxic effects of conventional drugs on various organ systems
Solution Approach 2:
The invention combines MSC secretome with cannabinoids in a composite therapeutic formulation. This composite approach leverages the synergistic effects of both components - MSC secretome for immunomodulation and tissue repair, and cannabinoids for inflammation control - to achieve effective anti-inflammatory therapy with minimal side effects
2Object-affected harmful factors
If MSC secretome and cannabinoids are combined to treat inflammatory diseases, then inflammation is reduced with minimal side effects, but the treatment complexity increases
Solution Approach 1:
The patent merges MSC secretome and cannabinoids into a single integrated therapeutic composition. This combination consolidates multiple therapeutic mechanisms (immunomodulation, anti-inflammatory, tissue repair) into one unified treatment, reducing the need for multiple separate medications and their associated side effects
Data Source
AI summary
Disclosed are compositions comprising a MSC secretome preparation and cannabinoids and methods of the use of said compositions for the treatment of inflammatory conditions.